Versamune HPV Could Bolster Long-Term Efficacy With Pembrolizumab in HPV16-Driven HNSCC
The growing incidence of head and neck squamous cell carcinoma (HNSCC) worldwide, driven by rising human papillomavirus (HPV)–related cases, is raising concerns about the increasing burden of this disease in the next decade.1 “In recent times, we’ve seen a …